The Discounted Cash Flow (DCF) valuation of Neuropace Inc (NPCE) is (12.24) USD. With the latest stock price at 10.42 USD, the upside of Neuropace Inc based on DCF is -217.4%.
Based on the latest price of 10.42 USD and our DCF valuation, Neuropace Inc (NPCE) is a sell. selling NPCE stocks now will result in a potential gain of 217.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 9.3% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (22.70) - (8.78) | (12.24) |
| Upside | -317.9% - -184.3% | -217.4% |